Last $103.73 USD
Change Today +1.05 / 1.02%
Volume 455.8K
LH On Other Exchanges
Symbol
Exchange
Berlin
As of 4:01 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

laboratory crp of amer hldgs (LH) Snapshot

Open
$103.12
Previous Close
$102.68
Day High
$103.89
Day Low
$102.44
52 Week High
09/9/14 - $108.77
52 Week Low
12/11/13 - $87.01
Market Cap
8.8B
Average Volume 10 Days
649.8K
EPS TTM
$6.17
Shares Outstanding
84.9M
EX-Date
--
P/E TM
16.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for LABORATORY CRP OF AMER HLDGS (LH)

laboratory crp of amer hldgs (LH) Related Businessweek News

No Related Businessweek News Found

laboratory crp of amer hldgs (LH) Details

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It offers a range of clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company provides testing services that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases. It also offers specialty testing services in the areas of allergy, clinical trials, diagnostic genetics, women's health, cardiovascular disease, identity, forensics, infectious disease, endocrine sciences, oncology, occupational testing, and pain management. The company provides its services through a sales force to the physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. It operates a national network of 44 primary laboratories and approximately 1,700 patient service centers, as well as branches and STAT laboratories. Laboratory Corporation of America Holdings has collaboration with university, hospital and academic institutions, such as Duke University, The Johns Hopkins University, the University of Minnesota, and Yale University to license and commercialize new diagnostic tests. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

34,000 Employees
Last Reported Date: 02/25/14
Founded in 1971

laboratory crp of amer hldgs (LH) Top Compensated Officers

Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $587.2K
Chief Legal Officer, Chief Compliance Officer...
Total Annual Compensation: $371.5K
Chief Medical Officer and Senior Vice Preside...
Total Annual Compensation: $345.3K
Compensation as of Fiscal Year 2013.

laboratory crp of amer hldgs (LH) Key Developments

Laboratory Corporation of America(R) Holdings and Monogram Biosciences, Inc. Introduces HIV-1 Next Generation Sequencing Assay to Support Drug Regimen Changes in HIV Suppressed Patients

Laboratory Corporation of America(R) Holdings and Monogram Biosciences Inc. announced the launch of HIV GenoSure Archive, the first laboratory test to help optimize antiretroviral (ARV) drug regimens in virally suppressed HIV patients. GenoSure Archive was developed using the Next Generation Sequencing (NGS) platform. Advances in HIV drug therapy have allowed patients to achieve and maintain complete suppression of viral replication. Life-long treatment, however, is necessary to maintain viral suppression. Such treatment therapies often have adverse side effects, and as new, more simplified ARV drug regimens become available, patients may benefit from new therapies. Previous laboratory testing to guide ARV drug selection required higher viral loads than what many patients have, leaving clinicians without a reliable diagnostic tool to guide ongoing therapy choices. HIV GenoSure Archive is the first genotypic drug resistance assay specifically designed to reliably identify the HIV DNA compartment, and it provides physicians and other HIV care providers with critical diagnostic information to support individualized and updated therapies for patients with low or undetectable viral loads of HIV-1. GenoSure Archive is performed by amplifying cell-associated HIV-1 DNA from infected cells in whole-blood samples and then analyzing the polymerase (pol) region using NGS methods. The assay is analytically validated to identify mutations associated with resistance to all members of the most widely utilized ARV drug classes. GenoSure Archive evaluates the full-length protease and integrase coding regions and amino acids 1 to 400 of the HIV-1 reverse transcriptase region. Resistance interpretations leverage Monogram's database of over 150,000 matched phenotype and genotype test results. GenoSure Archive is performed by amplifying cell-associated HIV-1 DNA from infected cells in whole-blood samples and then analyzing the polymerase (pol) region using NGS methods. The assay is analytically validated to identify mutations associated with resistance to all members of the most widely utilized ARV drug classes. GenoSure Archive evaluates the full-length protease and integrase coding regions and amino acids 1 to 400 of the HIV-1 reverse transcriptase region. Resistance interpretations leverage Monogram's database of over 150,000 matched phenotype and genotype test results.

LabCorp Launches Enlighten Health Genomics Business

Laboratory Corporation of America Holdings has launched Enlighten Health Genomics, a new business that reportedly builds on the diagnostic potential of Next-Generation Sequencing, or NGS, technology. Enlighten Health Genomics is part of LabCorp's Enlighten Health, an innovation engine for provider and patient-facing services and tools that enhance treatment decisions, lower healthcare costs and improve patient outcomes. Enlighten Health Genomics combines LabCorp's world-class infrastructure and capabilities with a team of accomplished geneticists to offer diagnostic capabilities, NGS analysis and interpretation, and informed genetic counseling.

LabCorp to Cut 57 Birmingham Jobs

LabCorp has plans to eliminate up to 57 jobs at its Birmingham office. According to a filing with the Alabama Department of Economic and Community Affairs, the reduction does not involve the closure of its Birmingham facility. The company's filing said the start date for the layoffs is Oct. 15.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LH:US $103.73 USD +1.05

LH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Reference Laboratories Inc $29.33 USD +0.08
Genomic Health Inc $33.65 USD +0.57
Myriad Genetics Inc $36.96 USD -1.04
QIAGEN NV €18.05 EUR +0.13
Quest Diagnostics Inc $63.76 USD +0.88
View Industry Companies
 

Industry Analysis

LH

Industry Average

Valuation LH Industry Range
Price/Earnings 17.1x
Price/Sales 1.5x
Price/Book 3.3x
Price/Cash Flow 14.2x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORY CRP OF AMER HLDGS, please visit www.labcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.